Literature DB >> 3533781

Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

T Decker, M L Lohmann-Matthes, M Baccarini.   

Abstract

Mature mononuclear phagocytes have been receiving much attention as effectors of spontaneous candidacidal activity, although with controversial results due to differences in the effector populations and the methods used in different laboratories. We here systematically compare the fungistatic activity of immature and mature cells of the murine macrophage series. The results show that nonadherent, nonphagocytic precursor cells (isolated either [90% purity] from bone marrow liquid cultures or from the organs of mice in which inflammatory conditions had been elicited in vivo) exerted a strong extracellular candidastatic activity. In contrast, mature macrophages, either obtained from different anatomical areas (spleen, liver, lung, peritoneal cavity) or matured in vitro from the precursor populations, displayed striking heterogeneity in their ability to inhibit the growth of Candida albicans, depending on the anatomical site they were derived from. Lymphokine activation did not alter the fungistatic pattern of the untreated cells. The different macrophage populations behaved very differently also in the production of reactive oxygen intermediates (ROI) in response to phagocytosis of C. albicans. The amounts of ROI generated, however, showed no correlation with candidastatic ability. Low levels of candidastatic activity exerted by resident peritoneal macrophages (good ROI producers) were inhibited by catalase, whereas high levels of growth inhibition by Kupffer cells (poor ROI producers) after 8 h of assay were hardly influenced by the enzyme. Our data suggest the existence of two different effector mechanisms in macrophage-mediated C. albicans growth inhibition, a rather inefficient ROI-dependent one, and a second, very efficient oxygen-independent mechanism. The implications of these findings are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3533781      PMCID: PMC260186          DOI: 10.1128/iai.54.2.477-486.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Managing systemic mycoses in the compromised host.

Authors:  S D Codish; J S Tobias
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats.

Authors:  R K Oldham; J R Ortaldo; H T Holden; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1977-04       Impact factor: 13.506

4.  Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).

Authors:  H G Meerpohl; M L Lohmann-Matthes; H Fischer
Journal:  Eur J Immunol       Date:  1976-03       Impact factor: 5.532

Review 5.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

6.  [Use of potassium chloride hypertonic saline solution (3M KC1) for extraction of soluble antigens from Candida albicans].

Authors:  P Marconi; F Bistoni; L Boncio; A Bersiani; P Bravi; M Pitzurra
Journal:  Ann Sclavo       Date:  1976 Jan-Feb

7.  Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes.

Authors:  P C Leijh; M T van den Barselaar; R van Furth
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

8.  Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes.

Authors:  R I Lehrer; K M Ladra; R B Hake
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Fungal infections in the cancer patient.

Authors:  G P Bodey
Journal:  S Afr Med J       Date:  1977-12-10

10.  Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi.

Authors:  C Nathan; N Nogueira; C Juangbhanich; J Ellis; Z Cohn
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  11 in total

1.  Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities.

Authors:  J E Wolf; A L Abegg; S J Travis; G S Kobayashi; J R Little
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway.

Authors:  S Krautwald; D Büscher; V Kummer; S Buder; M Baccarini
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells.

Authors:  L Pitzurra; R Fringuelli; S Perito; F Schiaffella; R Barluzzi; F Bistoni; A Vecchiarelli
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

6.  Phagocyte-mediated killing of Candida tropicalis.

Authors:  R A Lindemann; C K Franker
Journal:  Mycopathologia       Date:  1991-02       Impact factor: 2.574

7.  Acquired immunity in experimental murine aspergillosis is mediated by macrophages.

Authors:  L de Repentigny; S Petitbois; M Boushira; E Michaliszyn; S Sénéchal; N Gendron; S Montplaisir
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Isolation and partial characterization of glycolipid fractions from Mycobacterium avium serovar 2 (Mycobacterium paratuberculosis 18) that inhibit activated macrophages.

Authors:  M E Hines; J M Jaynes; S A Barker; J C Newton; F M Enright; T G Snider
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

Review 9.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

10.  The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans.

Authors:  R T Sawyer; A G Harmsen
Journal:  Mycopathologia       Date:  1989-11       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.